mayo clinic diet for glp 1 Beyond Ozempic: The GLP-1 boom Healthy weight loss when GLP-1s

We run a comprehensive metabolic panel not a 4-marker screen so we can rule out the things that complicate weight management (thyroid disease, insulin resistance, dyslipidemia, NAFLD markers, vitamin and mineral deficiencies, sleep apnea risk markers, hormonal contributors) before and during therapy

The authors advocate tailored monitoring protocols, including gradual dose titration at initiation and periodic renal function assessment in elderly patients to optimise safety outcomes in clinical practice

North America dominated the global GLP-1 receptor agonist market share by 76% in 2025

Expansion of digital prescription services and licensed online pharmacies is making home delivery more accessible

10.1056/NEJMoa2028395 71 NowakK

Grasset, E